Bard Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.62M Buy
37,985
+725
+2% +$66.6K 0.4% 65
2025
Q2
$3.25M Buy
37,260
+3,025
+9% +$257K 0.39% 66
2025
Q1
$3.08M Buy
34,235
+3,480
+11% +$311K 0.38% 67
2024
Q4
$2.46M Sell
30,755
-8,000
-21% -$693K 0.29% 73
2024
Q3
$3.49M Sell
38,755
-3,300
-8% -$278K 0.41% 59
2024
Q2
$3.31M Buy
42,055
+365
+0.9% +$29.9K 0.34% 64
2024
Q1
$3.63M Sell
41,690
-270
-0.6% -$23K 0.39% 60
2023
Q4
$3.46M Buy
41,960
+9,490
+29% +$723K 0.39% 61
2023
Q3
$2.54M Sell
32,470
-1,375
-4% -$115K 0.31% 70
2023
Q2
$2.98M Buy
33,845
+500
+1% +$43K 0.23% 94
2023
Q1
$2.69M Buy
33,345
+8,970
+37% +$731K 0.22% 96
2022
Q4
$1.89M Buy
24,375
+18,535
+317% +$1.5M 0.16% 118
2022
Q3
$472K Buy
5,840
+1,550
+36% +$139K 0.04% 195
2022
Q2
$385K Hold
4,290
0.04% 215
2022
Q1
$476K Hold
4,290
0.04% 197
2021
Q4
$444K Hold
4,290
0.04% 194
2021
Q3
$538K Hold
4,290
0.05% 180
2021
Q2
$533K Hold
4,290
0.05% 182
2021
Q1
$507K Hold
4,290
0.05% 174
2020
Q4
$503K Buy
+4,290
New +$472K 0.05% 178

Other funds holding MDT